Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -323.50K | -334.70K | -356.20K | -359.70K | -393.60K |
| Total Depreciation and Amortization | 90.90K | 79.00K | 78.70K | 79.40K | 79.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.20K | 15.40K | 3.90K | 4.00K | 4.00K |
| Change in Net Operating Assets | 212.10K | 229.10K | 270.10K | 283.50K | 304.20K |
| Cash from Operations | -7.20K | -11.00K | -3.30K | 7.40K | -5.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 43.80K | 39.30K | 48.80K | 39.60K | 46.90K |
| Total Debt Repaid | -32.80K | -44.00K | -51.00K | -71.90K | -45.10K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.90K | -3.60K | -1.80K | -24.00K | 1.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 700.00 | -14.60K | -5.20K | -16.60K | -4.30K |